Literature DB >> 31693228

Synthesis and Biological Activity of Short Interfering RNAs Having Several Consecutive Amide Internucleoside Linkages.

Venubabu Kotikam1, Julien A Viel1, Eriks Rozners1.   

Abstract

The success of RNA interference (RNAi) as a research tool and potential therapeutic approach has reinvigorated interest in chemical modifications of RNA. Replacement of the negatively charged phosphates with neutral amides may be expected to improve bioavailability and cellular uptake of small interfering RNAs (siRNAs) critical for in vivo applications. In this study, we introduced up to seven consecutive amide linkages at the 3'-end of the guide strand of an siRNA duplex. Modified guide strands having four consecutive amide linkages retained high RNAi activity when paired with a passenger strand having one amide modification between its first and second nucleosides at the 5'-end. Further increase in the number of modifications decreased the RNAi activity; however, siRNAs with six and seven amide linkages still showed useful target silencing. While an siRNA duplex having nine amide linkages retained some silencing activity, the partial reduction of the negative charge did not enable passive uptake in HeLa cells. Our results suggest that further chemical modifications, in addition to amide linkages, are needed to enable cellular uptake of siRNAs in the absence of transfection agents.
© 2020 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  RNA; RNA interference; chemical modifications; internucleoside amide linkage; nucleic acids

Mesh:

Substances:

Year:  2019        PMID: 31693228      PMCID: PMC6980941          DOI: 10.1002/chem.201903754

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  33 in total

1.  Monomers for preparation of amide linked RNA: Synthesis of C3'-homologated nucleoside amino acids from d-xylose.

Authors:  Paul Tanui; Martin Kullberg; Ni Song; Yashodhan Chivate; Eriks Rozners
Journal:  Tetrahedron       Date:  2010-07-01       Impact factor: 2.457

2.  Synthesis and properties of modified siRNA having amide-linked oligoribonucleosides at their 3' overhang regions.

Authors:  Reiko Iwase; Hideo Miyao; Takaaki Toyama; Kengo Nishimori
Journal:  Nucleic Acids Symp Ser (Oxf)       Date:  2006

3.  Solid-phase synthesis of modified RNAs containing amide-linked oligoribonucleosides at their 3'-end and their application to siRNA.

Authors:  Reiko Iwase; Takaaki Toyama; Kengo Nishimori
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2007       Impact factor: 1.381

4.  Concurrent Hydrogenation of Three Functional Groups Enables Synthesis of C3'-Homologated Nucleoside Amino Acids.

Authors:  Venubabu Kotikam; Eriks Rozners
Journal:  Org Lett       Date:  2017-07-21       Impact factor: 6.005

Review 5.  The current state and future directions of RNAi-based therapeutics.

Authors:  Ryan L Setten; John J Rossi; Si-Ping Han
Journal:  Nat Rev Drug Discov       Date:  2019-06       Impact factor: 84.694

6.  Can you trust your cancer cell lines?

Authors:  Asher Mullard
Journal:  Nat Rev Drug Discov       Date:  2018-08-30       Impact factor: 84.694

7.  Engineering small interfering RNAs by strategic chemical modification.

Authors:  Jesper B Bramsen; Jørgen Kjems
Journal:  Methods Mol Biol       Date:  2013

8.  Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs.

Authors:  David V Morrissey; Jennifer A Lockridge; Lucinda Shaw; Karin Blanchard; Kristi Jensen; Wendy Breen; Kimberly Hartsough; Lynn Machemer; Susan Radka; Vasant Jadhav; Narendra Vaish; Shawn Zinnen; Chandra Vargeese; Keith Bowman; Chris S Shaffer; Lloyd B Jeffs; Adam Judge; Ian MacLachlan; Barry Polisky
Journal:  Nat Biotechnol       Date:  2005-07-24       Impact factor: 54.908

9.  RNAi-mediated gene silencing in non-human primates.

Authors:  Tracy S Zimmermann; Amy C H Lee; Akin Akinc; Birgit Bramlage; David Bumcrot; Matthew N Fedoruk; Jens Harborth; James A Heyes; Lloyd B Jeffs; Matthias John; Adam D Judge; Kieu Lam; Kevin McClintock; Lubomir V Nechev; Lorne R Palmer; Timothy Racie; Ingo Röhl; Stephan Seiffert; Sumi Shanmugam; Vandana Sood; Jürgen Soutschek; Ivanka Toudjarska; Amanda J Wheat; Ed Yaworski; William Zedalis; Victor Koteliansky; Muthiah Manoharan; Hans-Peter Vornlocher; Ian MacLachlan
Journal:  Nature       Date:  2006-03-26       Impact factor: 49.962

10.  Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs.

Authors:  Jürgen Soutschek; Akin Akinc; Birgit Bramlage; Klaus Charisse; Rainer Constien; Mary Donoghue; Sayda Elbashir; Anke Geick; Philipp Hadwiger; Jens Harborth; Matthias John; Venkitasamy Kesavan; Gary Lavine; Rajendra K Pandey; Timothy Racie; Kallanthottathil G Rajeev; Ingo Röhl; Ivanka Toudjarska; Gang Wang; Silvio Wuschko; David Bumcrot; Victor Koteliansky; Stefan Limmer; Muthiah Manoharan; Hans-Peter Vornlocher
Journal:  Nature       Date:  2004-11-11       Impact factor: 49.962

View more
  2 in total

1.  Amide-Modified RNA: Using Protein Backbone to Modulate Function of Short Interfering RNAs.

Authors:  Venubabu Kotikam; Eriks Rozners
Journal:  Acc Chem Res       Date:  2020-07-13       Impact factor: 22.384

2.  Optimization of Automated Synthesis of Amide-Linked RNA.

Authors:  Julien A Viel; Chandan Pal; Eriks Rozners
Journal:  ACS Omega       Date:  2022-05-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.